BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 21732037)

  • 21. Treatment of acute lymphoblastic leukemia.
    Pui CH; Evans WE
    N Engl J Med; 2006 Jan; 354(2):166-78. PubMed ID: 16407512
    [No Abstract]   [Full Text] [Related]  

  • 22. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993.
    Rowe JM; Buck G; Burnett AK; Chopra R; Wiernik PH; Richards SM; Lazarus HM; Franklin IM; Litzow MR; Ciobanu N; Prentice HG; Durrant J; Tallman MS; Goldstone AH; ;
    Blood; 2005 Dec; 106(12):3760-7. PubMed ID: 16105981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol.
    Mancini M; Scappaticci D; Cimino G; Nanni M; Derme V; Elia L; Tafuri A; Vignetti M; Vitale A; Cuneo A; Castoldi G; Saglio G; Pane F; Mecucci C; Camera A; Specchia G; Tedeschi A; Di Raimondo F; Fioritoni G; Fabbiano F; Marmont F; Ferrara F; Cascavilla N; Todeschini G; Nobile F; Kropp MG; Leoni P; Tabilio A; Luppi M; Annino L; Mandelli F; Foà R
    Blood; 2005 May; 105(9):3434-41. PubMed ID: 15650057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial.
    Thomas X; Boiron JM; Huguet F; Dombret H; Bradstock K; Vey N; Kovacsovics T; Delannoy A; Fegueux N; Fenaux P; Stamatoullas A; Vernant JP; Tournilhac O; Buzyn A; Reman O; Charrin C; Boucheix C; Gabert J; Lhéritier V; Fiere D
    J Clin Oncol; 2004 Oct; 22(20):4075-86. PubMed ID: 15353542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial.
    Hunault M; Harousseau JL; Delain M; Truchan-Graczyk M; Cahn JY; Witz F; Lamy T; Pignon B; Jouet JP; Garidi R; Caillot D; Berthou C; Guyotat D; Sadoun A; Sotto JJ; Lioure B; Casassus P; Solal-Celigny P; Stalnikiewicz L; Audhuy B; Blanchet O; Baranger L; Béné MC; Ifrah N;
    Blood; 2004 Nov; 104(10):3028-37. PubMed ID: 15256423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia.
    Linker C; Damon L; Ries C; Navarro W
    J Clin Oncol; 2002 May; 20(10):2464-71. PubMed ID: 12011123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study.
    Annino L; Vegna ML; Camera A; Specchia G; Visani G; Fioritoni G; Ferrara F; Peta A; Ciolli S; Deplano W; Fabbiano F; Sica S; Di Raimondo F; Cascavilla N; Tabilio A; Leoni P; Invernizzi R; Baccarani M; Rotoli B; Amadori S; Mandelli F;
    Blood; 2002 Feb; 99(3):863-71. PubMed ID: 11806988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the L10M consolidation regimen to an alternative regimen including escalating methotrexate/L-asparaginase for adult acute lymphoblastic leukemia: a Southwest Oncology Group Study.
    Petersdorf SH; Kopecky KJ; Head DR; Boldt DH; Balcerzak SP; Wun T; Roy V; Veith RW; Appelbaum FR
    Leukemia; 2001 Feb; 15(2):208-16. PubMed ID: 11236936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL).
    Gökbuget N; Hoelzer D; Arnold R; Böhme A; Bartram CR; Freund M; Ganser A; Kneba M; Langer W; Lipp T; Ludwig WD; Maschmeyer G; Rieder H; Thiel E; Weiss A; Messerer D
    Hematol Oncol Clin North Am; 2000 Dec; 14(6):1307-25, ix. PubMed ID: 11147225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia.
    Kantarjian HM; O'Brien S; Smith TL; Cortes J; Giles FJ; Beran M; Pierce S; Huh Y; Andreeff M; Koller C; Ha CS; Keating MJ; Murphy S; Freireich EJ
    J Clin Oncol; 2000 Feb; 18(3):547-61. PubMed ID: 10653870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult patients with acute lymphoblastic leukemia: the ALL-87 study of the Japan Adult Leukemia Study Group (JALSG).
    Tanimoto M; Miyawaki S; Ino T; Kyo T; Sakamaki H; Naoe T; Hiraoka A; Asou N; Ohshima T; Tsubaki K; Kuriyama K; Ueda T; Minamil S; Okabe K; Saito H; Murakami H; Hirano M; Dohy H; Onozawa Y; Suzuki H; Ohno R
    Int J Hematol; 1998 Dec; 68(4):421-9. PubMed ID: 9885441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties.
    Chessells JM; Hall E; Prentice HG; Durrant J; Bailey CC; Richards SM
    Leukemia; 1998 Apr; 12(4):463-73. PubMed ID: 9557602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Larson RA; Dodge RK; Burns CP; Lee EJ; Stone RM; Schulman P; Duggan D; Davey FR; Sobol RE; Frankel SR
    Blood; 1995 Apr; 85(8):2025-37. PubMed ID: 7718875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of acute lymphoblastic leukemia in adults: results of the L-10 and L-10M protocols.
    Schauer P; Arlin ZA; Mertelsmann R; Cirrincione C; Friedman A; Gee TS; Dowling M; Kempin S; Straus DJ; Koziner B
    J Clin Oncol; 1983 Aug; 1(8):462-70. PubMed ID: 6583321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults.
    Hoelzer D; Thiel E; Löffler H; Büchner T; Ganser A; Heil G; Koch P; Freund M; Diedrich H; Rühl H
    Blood; 1988 Jan; 71(1):123-31. PubMed ID: 3422030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute lymphoblastic leukemia in patients aged 60 years and over: a population-based study of incidence and outcome.
    Taylor PR; Reid MM; Bown N; Hamilton PJ; Proctor SJ
    Blood; 1992 Oct; 80(7):1813-7. PubMed ID: 1382705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction therapy using the MRC UKALLXII/ECOG E2993 protocol in Chinese adults with acute lymphoblastic leukemia.
    Wang H; Chen XQ; Geng QR; Liu PP; Lin GN; Xia ZJ; Lu Y
    Int J Hematol; 2011 Aug; 94(2):163-168. PubMed ID: 21732037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Progress of chemotherapy in adult acute leukemia].
    Ohno R
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):431-6. PubMed ID: 7887634
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.